Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain

@article{Wissel2006LowDT,
  title={Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain},
  author={J{\"o}rg Wissel and Tanja Haydn and J{\"o}rg M{\"u}ller and Christian Brenneis and Thomas Berger and Werner Poewe and Ludwig D. Schelosky},
  journal={Journal of Neurology},
  year={2006},
  volume={253},
  pages={1337-1341}
}
About 30% of patients with chronic upper motor neuron syndrome (UMNS) suffer from disabling spasticity-related pain not sufficiently correctable by conventional treatment. Delta9-tetrahydrocannabinol (Δ9-THC) was reported to add benefit in the treatment of pain in patients with multiple sclerosis (MS). The question arose whether synthetic cannabinoids with lower potential for psychotropic side effects could be effective as well. To evaluate the safety and efficacy of low dose treatment with the… 
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis
TLDR
Clinical studies on cannabis-based medicine extract (CBME), in particular nabiximols, in spasticity, as well as pain, and bladder dysfunction in MS are analyzed.
Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial.
TLDR
Nabilone as an adjunctive to GBP is an effective, well-tolerated combination for MS-induced NPP, and this study identifies a novel therapeutic combination for use in this population of patients predisposed to tolerability issues that may otherwise prevent effective pain management.
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances
TLDR
Their adverse side-effect profile has generally been mild compared with other drugs used for pain and spasticity; nonetheless, there is still concern about potential long-term side effects, particularly psychiatric side effects and effects on fetal development.
Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
TLDR
Patients with unsatisfactory response to other methods of pain therapy and who were characterized by failed stress adaptation particularly benefited from treatment with cannabinoids, but none of the attempts to overcome the disadvantage of the narrow therapeutic index have resulted in a major breakthrough.
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
  • Paul F. Smith
  • Psychology
    Therapeutics and clinical risk management
  • 2010
TLDR
The available clinical trial data suggest that the adverse side effects associated with using CBMEs are generally mild, but there may be reason to be concerned about the use of therapeutic cannabinoids by adolescents, people predisposed to psychosis and pregnant women.
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
TLDR
This is the first randomized controlled trial demonstrating the benefits of nabilone on headache, analgesic consumption and the quality of life in patients with intractable MOH and this drug appears to be safe and well-tolerated.
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
TLDR
Evidence is found that combined THC and CBD extracts may provide therapeutic benefit for MS spasticity symptoms and subjective assessment of symptom relief did often show significant improvement post-treatment.
Effective treatment of spasticity using dronabinol in pediatric palliative care.
  • M. Kuhlen, J. Hoell, G. Janssen
  • Medicine
    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
  • 2016
The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms
TLDR
Oromucosal spray and oral cannabis are mainly used for treating patients with MS and have positive effects on treating the most common symptoms of MS, such as pain and spasticity, whereas the other MS symptoms indicated slight improvement, for which further studies are needed.
Reassessment of the role of cannabinoids in the management of pain
TLDR
There is increasing evidence that cannabinoids are safe and effective for refractory chronic pain conditions including neuropathic pain associated with multiple sclerosis, rheumatoid arthritis, and peripheral neuropathy associated with HIV/AIDS.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Are oral cannabinoids safe and effective in refractory neuropathic pain?
TREATMENT OF SPASTICITY IN SPINAL CORD INJURY WITH DRONABINOL, A TETRAHYDROCANNABINOL DERIVATIVE
TLDR
This trial of dronabinol, a THC derivative, for the treatment of spasticity in the spinal-cord-injured population demonstrated highly individualized emotional changes as indicated by increases and/or decreases in the dysphoric mood scales.
Management of spasticity associated pain with botulinum toxin A.
Treatment of Human Spasticity with Δ9‐Tetrahydrocannabinol
TLDR
Benefit was seen in three of three patients with “tonic spasms” and no benefit was noted in patients with cerebellar disease, but animal studies suggest that THC has an inhibitory effect on polysynaptic reflexes.
Delta-9-THC in the treatment of spasticity associated with multiple sclerosis.
TLDR
There was significant improvement in patient ratings of spasticity compared to placebo at doses greater than 7.5 mg, suggesting a role for THC in the treatment ofSpasticity in multiple sclerosis.
Nabilone. A preliminary review of its pharmacological properties and therapeutic use.
TLDR
Nabilone offers an effective alternative to the treatment options available in a difficult therapeutic area - those patients with severe gastrointestinal side effects from cancer chemotherapy who are refractory to conventional therapy.
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
TLDR
Benefit was seen in three of three patients with "tonic spasms" and no benefit was noted in patients with cerebellar disease, and animal studies suggest that THC has an inhibitory effect on polysynaptic reflexes.
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
TLDR
Nabilone is an effective oral anti-emetic drug for moderately toxic chemotherapy, but the range and unpredictability of its side-effects warrant caution in its use.
Anti-spasticity agents for multiple sclerosis.
TLDR
The rationale for treating features of the upper motor neurone syndrome must be better understood and sensitive, validated spasticity measures need to be developed.
...
1
2
3
4
...